Pentaxim®
Adsorbed Diphtheria and Tetanus Vaccine, Acellular Pertussis Vaccine, Inactivated Poliomyelitis Vaccine, and Haemophilus influenzae type b Conjugate Vaccine.1
Indications
Active immunization against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease caused by Haemophilus influenzae type b (including meningitis, septicemia, cellulitis, arthritis, epiglottitis, pneumonia, osteomyelitis, and others).1
Age of Use
For primary vaccination of children from 2 months of age and for revaccination after completion of the primary immunization course.1
Vaccination Schedule
- According to the National Immunization Schedule of the Russian Federation, the primary vaccination course consists of three doses administered at 1.5-month intervals, at the ages of 3, 4.5, and 6 months.1
- Other three-dose immunization schedules may be used based on a physician’s recommendation (e.g., 2–3–4 months, 2–4–6 months, or 3–4–5 months).
- Revaccination: After the primary series, a booster dose should be administered from 11 months of age.1,2
Manufacturing and Registration
- Registered in the Russian Federation since 2008 via the national procedure under Federal Law No. 61.1
- On 08 September 2023, the registration dossier was brought into compliance with EAEU requirements.1
- Marketing Authorization Holder: Sanofi Winthrop Industrie, France.1
- Manufactured in the Russian Federation at the Nanolek Biomedical Complex since 2017 and supplied annually within the National Immunization Program.3
Official Documents
- 1.
- 2.
- 3.